Literature DB >> 1376347

Human recognition of T cell epitopes on the Plasmodium vivax circumsporozoite protein.

S Herrera1, P Escobar, C de Plata, G I Avila, G Corradin, M A Herrera.   

Abstract

In order to identify T cell epitopes recognized by human in the Plasmodium vivax circumsporozoite protein, 28 overlapping synthetic peptides spanning the entire circumsporozoite protein were tested for their ability to stimulate proliferation of PBMC from 22 adults living in a malaria-endemic area of the Colombian Pacific Coast and from four individuals who never had a history of malaria infection. In addition, BALB/c mice were immunized with pools of peptides, and their lymph node cells were stimulated in vitro with individual peptides. Four epitopes were recognized by human lymphocytes but not all of them by mice. One of the epitopes was located inside the central repetitive B cell immunodominant domain. Several of the variants of the repeats were recognized by about one-third of the studied individuals. Another T cell epitope was located in the amino terminus and the other two in the carboxyl region. Peptides were recognized by both immune and nonimmune donors. Some of them were frequently recognized suggesting a lack of genetic restriction, whereas some others were recognized by only a few individuals but induced strong proliferation. These epitopes may be of potential value for a malaria subunit vaccine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376347

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

2.  Antigenic diversity of the Plasmodium vivax circumsporozoite protein in parasite isolates of Western Colombia.

Authors:  Miguel Ángel Hernández-Martínez; Ananías A Escalante; Myriam Arévalo-Herrera; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

3.  Identification of murine B-cell and T-cell epitopes of Escherichia coli outer membrane protein F with synthetic polypeptides.

Authors:  K M Williams; E C Bigley; R B Raybourne
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax.

Authors:  Y Zevering; C Khamboonruang; K Rungruengthanakit; L Tungviboonchai; J Ruengpipattanapan; I Bathurst; P Barr; M F Good
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

5.  Balancing selection and high genetic diversity of Plasmodium vivax circumsporozoite central region in parasites from Brazilian Amazon and Rio de Janeiro Atlantic Forest.

Authors:  Natália Ketrin Almeida-de-Oliveira; Rebecca de Abreu-Fernandes; Lidiane Lima-Cury; Aline Rosa de Lavigne; Anielle de Pina-Costa; Daiana de Souza Perce-da-Silva; Marcos Catanho; Atila Duque Rossi; Patrícia Brasil; Cláudio Tadeu Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

6.  Differing patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens.

Authors:  Christian M Parobek; Jeffrey A Bailey; Nicholas J Hathaway; Duong Socheat; William O Rogers; Jonathan J Juliano
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17

7.  Predicting HLA CD4 Immunogenicity in Human Populations.

Authors:  Sandeep Kumar Dhanda; Edita Karosiene; Lindy Edwards; Alba Grifoni; Sinu Paul; Massimo Andreatta; Daniela Weiskopf; John Sidney; Morten Nielsen; Bjoern Peters; Alessandro Sette
Journal:  Front Immunol       Date:  2018-06-14       Impact factor: 7.561

8.  Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine.

Authors:  Myriam Arévalo-Herrera; Xiomara Gaitán; Michelle Larmat-Delgado; María Alejandra Caicedo; Sonia M Herrera; Juliana Henao-Giraldo; Angélica Castellanos; Jean-Christophe Devaud; André Pannatier; José Oñate; Giampietro Corradin; Sócrates Herrera
Journal:  Nat Commun       Date:  2022-03-25       Impact factor: 17.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.